Similar articles for PMID: 36302103

Year	Number of Results
1986	1
1990	1
1991	1
1996	1
1998	4
1999	5
2000	7
2001	2
2002	4
2003	3
2004	3
2005	11
2006	4
2007	4
2008	2
2009	2
2010	3
2011	6
2012	7
2013	4
2014	4
2015	1
2016	7
2017	8
2018	6
2019	3
2020	2
2021	4
2022	3
2024	0

1

International normalized ratio and activated partial thromboplastin time testing.

Chornenki NLJ, Fralick M, Sholzberg M. Chornenki NLJ, et al. CMAJ. 2022 Aug 29;194(33):E1135. doi: 10.1503/cmaj.220629. CMAJ. 2022. PMID: 36302103 Free PMC article. No abstract available.

2

Use of different thromboplastin reagents causes greater variability in international normalized ratio results than prolonged room temperature storage of specimens.

Davis KD, Danielson CF, May LS, Han ZQ. Davis KD, et al. Arch Pathol Lab Med. 1998 Nov;122(11):972-7. Arch Pathol Lab Med. 1998. PMID: 9822125

3

Optimal dosing of subcutaneous unfractionated heparin for the treatment of deep vein thrombosis.

Kearon C, Harrison L, Crowther M, Ginsberg JS. Kearon C, et al. Thromb Res. 2000 Mar 15;97(6):395-403. doi: 10.1016/s0049-3848(99)00189-9. Thromb Res. 2000. PMID: 10704648 Clinical Trial.

4

The danger of relying on the APTT and PT in patients on DOAC therapy, a potential patient safety issue.

Adcock DM, Gosselin RC. Adcock DM, et al. Int J Lab Hematol. 2017 May;39 Suppl 1:37-40. doi: 10.1111/ijlh.12658. Int J Lab Hematol. 2017. PMID: 28447415 Review.

5

Prothrombin time and partial thromboplastin time assay considerations.

Ng VL. Ng VL. Clin Lab Med. 2009 Jun;29(2):253-63. doi: 10.1016/j.cll.2009.05.002. Clin Lab Med. 2009. PMID: 19665677 Review.

6

Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a review of the literature and current guidelines for testing.

Levy JH, Szlam F, Wolberg AS, Winkler A. Levy JH, et al. Clin Lab Med. 2014 Sep;34(3):453-77. doi: 10.1016/j.cll.2014.06.005. Epub 2014 Jul 28. Clin Lab Med. 2014. PMID: 25168937 Review.

7

Coagulation assays.

Bates SM, Weitz JI. Bates SM, et al. Circulation. 2005 Jul 26;112(4):e53-60. doi: 10.1161/CIRCULATIONAHA.104.478222. Circulation. 2005. PMID: 16043649 No abstract available.

8

Utilization of coagulation assays in clinical therapeutics.

Peters GL, Erwin PB, Pitlick MK, Stacy ZA. Peters GL, et al. Pharmacotherapy. 2013 Nov;33(11):1214-22. doi: 10.1002/phar.1283. Epub 2013 May 17. Pharmacotherapy. 2013. PMID: 23686890 Review.

9

International collaborative study for the calibration of proposed International Standards for thromboplastin, rabbit, plain, and for thromboplastin, recombinant, human, plain.

van den Besselaar AMHP, Chantarangkul V, Angeloni F, Binder NB, Byrne M, Dauer R, Gudmundsdottir BR, Jespersen J, Kitchen S, Legnani C, Lindahl TL, Manning RA, Martinuzzo M, Panes O, Pengo V, Riddell A, Subramanian S, Szederjesi A, Tantanate C, Herbel P, Tripodi A. van den Besselaar AMHP, et al. J Thromb Haemost. 2018 Jan;16(1):142-149. doi: 10.1111/jth.13879. Epub 2017 Dec 1. J Thromb Haemost. 2018. PMID: 29065247 Free article.

10

Does ISI of thromboplastin affect the INR value?

Sitalakshmi S, Srikrishna A, Shanthala DA, Damodar P. Sitalakshmi S, et al. J Assoc Physicians India. 2005 May;53:493-4. J Assoc Physicians India. 2005. PMID: 16124366 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year